Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity

Planta Medica

Volumn 77, Issue 2, 2011, Pages 196-204

  Harris, Cory S ^a,b,c   Beaulieu, Louis Philippe ^a,c   Fraser, Marie Hélne ^c,d,e   McIntyre, Kristina L ^a,c   Owen, Patrick L ^c,f   Martineau, Louis C ^c,d   Cuerrier, Alain ^c,d   Johns, Timothy ^c,e,f   Haddad, Pierre S ^c,d   Bennett, Steffany A L ^b,c   Arnason, John T ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

advanced glycation end products; antioxidants; diabetes; diabetic complications; oxidative stress; plant phenolics

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; FREE RADICAL; LOW DENSITY LIPOPROTEIN; PHENOL DERIVATIVE; PLANT EXTRACT;

ANTIGLYCATION ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; FLUOROMETRY; GAULTHERIA; IC 50; IMMUNOLOGICAL PROCEDURES; IN VITRO STUDY; LINGONBERRY; LYCOPODIUM; MEDICINAL PLANT; NONHUMAN;

ANTIOXIDANTS; CANADA; FREE RADICAL SCAVENGERS; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; MALONDIALDEHYDE; OXIDATION-REDUCTION; PHENOLS; PLANT EXTRACTS; PLANTS, MEDICINAL; TIME FACTORS;

EID: 78651501348     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250161     Document Type: Article

References (39)

1. Meetoo D, McGovern P, Safadi R. An epidemiological overview of diabetes across the world. Br J Nurs 2007 16 1002-1007
2. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001 56 1-21
3. Ramasamy R. Glycation and RAGE: Common links in the pathogenesis of microvascular and macrovascular complications of diabetes. Can J Diabetes 2006 30 422-429
4. Bierhaus A, Humpert P M., Morcos M, Wendt T, Chavakis T, Arnold B, Stern D M., Nawroth P P. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005 83 876-886
5. Young T K., Reading J, Elias B, O'Neil J D. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000 163 561-566
6. Assembly of First Nations. A First Nations Diabetes Report Card. Part 1: Marking a path to community wellness. Ottawa, ON Assembly of First Nations 2006 31
7. Booth G L., Hux J E., Fang J, Chan B T. Time trends and geographic disparities in acute complications of diabetes in Ontario, Canada. Diabetes Care 2005 28 1045-1050
8. Young T K., Reading J, Elias B, O'Neil J D. Type 2 diabetes mellitus in Canada's first nations: status of an epidemic in progress. CMAJ 2000 163 561-566
9. Yu C H., Zinman B. Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Res Clin Pract 2007 78 159-170
10. Wu C H., Yen G C. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem 2005 53 3167-3173
11. Fraser M-H, Cuerrier A, Haddad P, Arnason J T., Owen P, Johns T. Medicinal plants of Cree communities (Québec, Canada): antioxidant activity of plants used to treat type 2 diabetes symptoms. Can J Physiol Pharmacol 2007 85 1200-1214
12. Spoor D C., Martineau L C., Leduc C, Benhaddou-Andaloussi A, Meddah B, Harris C, Burt A, Fraser M H., Coonishish J, Joly E, Cuerrier A, Bennett S A., Johns T, Prentki M, Arnason J T., Haddad P S. Selected plant species from the Cree pharmacopoeia of northern Quebec possess anti-diabetic potential. Can J Physiol Pharmacol 2006 84 847-858
13. Leduc C, Coonishish J, Haddad P, Cuerrier A. Plants used by the Cree Nation of Eeyou Istchee (Quebec, Canada) for the treatment of diabetes: a novel approach in quantitative ethnobotany. J Ethnopharmacol 2006 105 55-63
14. Harbilas D, Martineau L C., Harris C S., Adeyiwola-Spoor D C. A., Saleem A, Lambert J, Caves D, Johns T, Prentki M, Cuerrier A, Arnason J T., Bennett S A. L., Haddad P S. Evaluation of the anti-diabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II. Can J Physiol Pharmacol 2009 87 479-492
15. Beaulieu L P., Harris C S., Saleem A, Cuerrier A, Haddad P S., Martineau L C., Bennett S A., Arnason J T. Inhibitory effect of the Cree traditional medicine wiishichimanaanh (Vaccinium vitis-idaea) on advanced glycation endproduct formation: identification of active principles. Phytother Res 2009 24 741-747
16. Suzuki R, Okada Y, Okuyama T. Two flavone C-glycosides from the style of Zea mays with glycation inhibitory activity. J Nat Prod 2003 66 564-565 (Pubitemid 36531914)
17. Singleton V L., Rossi Jr. J A. Colorimetry of total phenolics with phosphomolybdic-phosphotungistic acid reagents. Am J Enol Vitic 1965 16 144-158
18. Gillespie K M., Chae J M., Ainsworth E A. Rapid measurement of total antioxidant capacity in plants. Nat Protoc 2007 2 867-870
19. Cotelle N, Bernier J L., Catteau J P., Pommery J, Wallet J C., Gaydou E M. Antioxidant properties of hydroxy-flavones. Free Radic Biol Med 1996 20 35-43
20. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989 6 67-75
21. Sobal G, Menzel J, Sinzinger H. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot Essent Fatty Acids 2000 63 177-186
22. Harris C S., Lambert J, Saleem A, Coonishish J, Martineau L C., Cuerrier A, Haddad P S., Arnason J T., Bennett S A. L. Anti-diabetic activity of extracts from needle, bark and cone of Picea glauca: organ specific protection from glucose toxicity and glucose deprivation. Pharm Biol 2008 46 126-134
23. Martineau L C., Muhammad A, Saleem A, Herve J, Harris C S., Arnason J T., Haddad P S. Anti-adipogenic activities of Alnus incana and Populus balsamifera bark extracts, part II: bioassay-guided identification of actives salicortin and oregonin. Planta Med 2010
24. Saleem A, Harris C S., Asim M, Cuerrier A, Martineau L, Haddad P S., Arnason J T. A RP-HPLC-DAD-APCI/MSD method for the characterisation of medicinal Ericaceae used by the Eeyou Istchee Cree First Nations. Phytochem Anal 2010
25. Munch G, Thome J, Foley P, Schinzel R, Riederer P. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Brain Res Rev 1997 23 134-143
26. Kilhovd B K., Juutilainen A, Lehto S, Ronnemaa T, Torjesen P A., Hanssen K F., Laakso M. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia 2007 50 1409-1417
27. Peng X, Cheng K W., Ma J, Chen B, Ho C T., Lo C, Chen F, Wang M. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem 2008 56 1907-1911
28. Sultana N, Choudhary M I., Khan A. Protein glycation inhibitory activities of Lawsonia inermis and its active principles. J Enzyme Inhib Med Chem 2009 24 257-261
29. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 2001 131 235-241
30. Kale A, Gawande S, Kotwal S, Netke S, Roomi W, Ivanov V, Niedzwiecki A, Rath M. Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract. Phytother Res 2009 24 (Suppl. 1) S48-S55
31. Franke A A., Ashburn L A., Kakazu K, Suzuki S, Wilkens L R., Halm B M. Apparent bioavailability of isoflavones after intake of liquid and solid soya foods. Br J Nutr 2009 102 1203-1210
32. Wautier M P., Massin P, Guillausseau P J., Huijberts M, Levy B, Boulanger E, Laloi-Michelin M, Wautier J L. N(carboxymethyl)lysine as a biomarker for microvascular complications in type 2 diabetic patients. Diabetes Metab 2003 29 44-52
33. Fernandez M T., Mira M L., Florencio M H., Jennings K R. Iron and copper chelation by flavonoids: an electrospray mass spectrometry study. J Inorg Biochem 2002 92 105-111
34. Kim D O., Lee C Y. Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Crit Rev Food Sci Nutr 2004 44 253-273
35. Urios P, Grigorova-Borsos A M., Sternberg M. Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur J Nutr 2007 46 139-146
36. Baderschneider B, Winterhalter P. Isolation and characterization of novel benzoates, cinnamates, flavonoids, and lignans from Riesling wine and screening for antioxidant activity. J Agric Food Chem 2001 49 2788-2798
37. Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 2003 11 5317-5323
38. Peyroux J, Sternberg M. Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes. Pathol Biol (Paris) 2006 54 405-419
39. Ferreira M L., Lang G C. Indigenous peoples and diabetes: community empowerment and wellness. Durham, North Carolina Carolina Academic Press 2006 549